• USA Home
  • S1196 - α-Synuclein A30P human

EMAIL THIS PAGE TO A FRIEND
S1196 Sigma

α-Synuclein A30P human

recombinant, expressed in E. coli, N-terminal histidine tagged, ≥90% (SDS-PAGE), lyophilized powder

Purchase

Properties

Related Categories Cell Biology, Cell Signaling and Neuroscience, Neurobiology, Neuroscience, Parkinson′s Disease,
recombinant   expressed in E. coli
assay   ≥90% (SDS-PAGE)
form   lyophilized powder
shipped in   dry ice
storage temp.   −20°C
Gene Information   human ... SNCA(6622)

Description

Biochem/physiol Actions

A point mutation in the α-synuclein gene, Ala30-Pro (A30P), linked to familial Parkinson′s disease.

Price and Availability


All labs need water
Safety & Documentation

Safety Information

RIDADR 
NONH for all modes of transport
WGK Germany 
3
Protocols & Articles

Articles

Parkinson's Disease

Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's disease, affecting more than 6 million people worldwide. PD is a slowly progressing motor system neurod...
Carolyn L. Crankshaw
BioFiles v7 n2, 2011, 16–20
Keywords: Alzheimer Disease, Apoptosis, Chromatin immunoprecipitation, Clinical, Degradations, Dopamine agents, Gene expression, Parkinson Disease, Polymorphisms

Peer-Reviewed Papers
15

References

Related Products

Technical Service:

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Bulk Ordering & Pricing:

Need larger quantities for your development, manufacturing or research applications?